Filter
4508
Filtered Results: 4508
Text search:
National
Center
for
Disease
Prevention
and
Control
Department
of
Health,
Philippines
Featured
Recommendations
399
New Publications
1277
Language
Document type
No document type
2685
Studies & Reports
709
Guidelines
585
Manuals
236
Strategic & Response Plan
164
Training Material
53
Situation Updates
34
Fact sheets
29
Infographics
5
Resource Platforms
4
Brochures
3
App
1
Countries / Regions
India
234
Global
171
Kenya
134
South Africa
103
Sierra Leone
96
Nigeria
95
Ethiopia
91
Uganda
89
Liberia
87
Western and Central Europe
84
Nepal
80
Latin America and the Carribbean
80
Malawi
74
Zambia
69
Tanzania
64
Africa
59
Ghana
56
Philippines
56
Myanmar / Burma
53
Rwanda
48
Bangladesh
46
Ukraine
39
Eastern Europe
36
Mozambique
35
Namibia
35
Brazil
35
Congo, Democratic Republic of
33
Asia
33
Zimbabwe
32
South–East Asia Region
32
Syria
29
Haiti
28
Cambodia
28
Guinea
25
Lesotho
24
Senegal
22
Russia
22
South Sudan
21
Botswana
21
Indonesia
20
Colombia
20
Middle East and North Africa
17
USA
16
Pakistan
16
Germany
16
East and Southern Africa
16
West and Central Africa
15
Thailand
14
Eastern Europe and Central Asia
14
Yemen
12
Afghanistan
11
Eswatini/ Swaziland
11
Albania
11
Burkina Faso
10
Cameroon
10
Western Pacific Region
10
Madagascar
9
Chile
9
Tajikistan
9
Angola
8
Paraguay
8
Venezuela
8
Jordan
7
China
7
Argentina
7
Peru
7
Laos
7
Moldova
7
Georgia
7
Vietnam
7
Mali
6
Somalia
6
Sudan
6
Benin
6
Sri Lanka
6
Papua New Guinea
5
Ecuador
5
North America
5
Iraq
4
Lebanon
4
Turkey
4
Bolivia
4
Poland
4
Armenia
4
Southern Africa
4
Guinea-Bissau
3
Togo
3
Chad
3
Gambia
3
Central African Republic
3
North Macedonia
3
Hungary
3
Honduras
3
Palestine
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Japan
3
United Kingdom
3
Spain
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Malaysia
2
Burundi
2
Mexico
2
Iran
2
Turkmenistan
2
Portugal
2
Morocco
1
Niger
1
Egypt
1
Mauritania
1
Ireland
1
Singapore
1
Dominican Republic
1
Serbia
1
El Salvador
1
Greece
1
Libya
1
Other region
1
Bhutan
1
Qatar
1
Bulgaria
1
Estonia
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1750
Clinical Guidelines
403
Public Health
291
Women & Child Health
193
Key Resources
184
Capacity Building
66
Pharmacy & Technologies
47
Toolboxes
HIV
384
COVID-19
334
TB
328
Mental Health
312
Rapid Response
188
AMR
183
Ebola
151
Planetary Health
144
NTDs
119
Caregiver
113
NCDs
98
Disability
78
Conflict
78
Pharmacy
66
Global Health Education
64
Refugee
63
Zika
58
Natural Hazards
46
Health Financing Toolbox
39
Specific Hazards
32
Cholera
26
Polio
24
Social Ethics
6
Typhoon
3
South Sudan
1
Health Financing
1
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners ... affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contributions were shared through 70 presentations made by stake holders from all Regions. The presentations covered the key strategic approaches: global context, challenges in countries, contact tracing and post exposure prophylaxis, disability care, interruption of transmission and elimination of disease, stigma and d iscrimination, research. In addition to numerous comments received through the chat box and by email, the conclusions and recommendations of this Consultation will guide finalizing the post 2020 Global Leprosy Strategy.
This document provides information to assist countries in developing exit screening plans and Standard Operating Procedures (SOP). This includes the method, tools, and sequence ... screening; determining resource needs; communication messages; and the legal considerations of screening.
With Safety Tips for Conducting Community Meetings
Updated July 2020
This document includes key Risk Communication and Community Engagement (RCCE) considerations during shifting lockdown measures,...
Growing evidence indicates that large proportions of children around the world experience physical, sexual and emotional violence every year, with enormous implications ... human rights, public health and economic and social development.1 Over the last five years, national governments and Together for Girls – a global public-private partnership comprising UNICEF,
other United Nations (UN) agencies, the United States (US) Government and various private sector agencies – have worked to mobilize and sustain a global movement to end violence against children, with a focus on sexual violence against girls.
This manual has been developed to guide rapid risk assessment of acute public health risks from any type of hazard in response to requests from Mem...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, health...
o support and guide countries and partners to strengthen a health systems response to address violence against women, WHO has produced several tool...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention ... control. 7.Treatment outcome. I.World Health Organization
The Lancet Planetary Health Volume 5, ISSUE 7, e466-e478, July 01, 2021
Transmission of many infectious diseases depends on interactions between ...
2nd. edition
The new edition has been developed to make widely available to programme managers, health care workers in endemic settings, academic researchers, and other key partners, a concise sour...
The report is geared towards mayors, local government officials and city policy planners.It highlights key areas where city leaders can tackle the drivers of NCDs, including tobacco use, air polluti...
The present National action plan on antimicrobial resistance (AMR) with component of antimicrobial consumption (AMC) covering both human and agricu...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense...
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the ... as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, information will be needed to support a potential campaign to promote vaccination.
Objective: The aim of this study was to determine the variables affecting the likelihood of refusal and indecision toward a vaccine against COVID-19 and to determine the acceptance of the vaccine for different scenarios of effectiveness and side effects.
Materials and Methods: A multinomial logistic regression method based on the Health Belief Model was used to estimate the current methodology, using data obtained by an online anonymous survey of 370 respondents in Chile.
Results: The results indicate that 49% of respondents were willing to be vaccinated, with 28% undecided or 77% of individuals who would potentially be willing to be inoculated. The main variables that explained the probability of rejection or indecision were associated with the severity of COVID-19, such as, the side effects and effectiveness of the vaccine; perceived benefits, including immunity, decreased fear of contagion, and the protection of oneself and the environment; action signals, such as, responses from ones' family and the government, available information, and specialists' recommendations; and susceptibility, including the contagion rate per 1,000 inhabitants and relatives with COVID-19, among others. Our analysis of hypothetical vaccine scenarios revealed that individuals preferred less risky vaccines in terms of fewer side effects, rather than effectiveness. Additionally, the variables that explained the indecision toward or rejection of a potential COVID-19 vaccine could be used in designing public health policies.
Conclusions: We discovered that it is necessary to formulate specific, differentiated vaccination-promotion strategies for the anti-vaccine and undecided groups based on the factors that explain the probability of individuals refusing or expressing hesitation toward vaccination.
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden ... has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, ... are primarily aimed at preventing and mitigating human-to-human transmission. These plans carry presumptive weight and are increasingly being operationalized at the national, regional and international level with the support of the World Health Organization (WHO). The conventional focus of pandemic preparedness for EIDs of zoonotic origin has been on public health and human welfare. However, thisfocus on human populations has resulted in strategically important disciplinary silos. As the risks of zoonotic diseases have implications that reach across many domains outside traditional public health, including anthropological, environmental, and veterinary fora, a more inclusive ecological perspective is paramount for an effective response to future outbreaks.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully trans...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP...
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test ... rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other national health guidelines. It is intended to serve as the main guiding document for national, regional and local programme managers, clinicians, coordinators, laboratory staff and other health workers; national and regional reference laboratories; local and international implementing partners; and donors involved in TB control.
This paper explores the angles and opportunities of digital health, with a look
at digital innovation ... its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging technology for better circulatory health and to capture the roles that various sectors have in making
digital health a tool for everyone.
